Cvasciuc I T, Gull S, Oprean R, Lim K H, Eatock F
Royal Victoria Hospital, United Kingdom of Great Britain and Northern Ireland.
Ulster Hospital, Dundonald, Belfast, United Kingdom of Great Britain and Northern Ireland.
Acta Endocrinol (Buchar). 2020 Jan-Mar;16(1):78-85. doi: 10.4183/aeb.2020.78.
Pheochromocytomas and paragangliomas (PCC/PGLs) are diagnosed variously with increasing incidence and changing clinical and pathology pattern.
The aim was to further characterize PCC/PGLs in a stable population.
A retrospective, single institution study analysed adrenalectomies for PCC/PGLs between January 2010 - January 2019. Demographics, symptoms, blood pressure, preoperative hormones, imaging, histology, hospital stay, complications and three subgroups [based on the modality of diagnosis - incidentaloma group (IG), genetic group (GG) and symptomatic group (SG)] were noted.
86 patients included IG 51 (59.3%), GG 10 (11.62%) and SG 25 patients (29.06%). Incidence was 5.30 cases/1 million population. 33.34% of the IG had a delayed diagnosis with a mean interval of 22.95 months (4-120 months). Females presented more often with paroxysmal symptoms (PS) (p=0.011). Patients with PS and classic symptoms were younger (p=0.0087, p=0.0004) and those with PS required more inotropes postoperatively (p=0.014). SG had higher preoperative hormone levels (p=0.0048), larger tumors (p=0.0169) and more likely females. GG are younger compared with those from the IG (p=0.0001) or SG (p= 0.178).
Majority of patients had an incidental and delayed diagnosis. If symptomatic, patients are more likely to be young females with higher hormone levels and larger tumors.
嗜铬细胞瘤和副神经节瘤(PCC/PGLs)的诊断方式多样,其发病率不断上升,临床和病理模式也在发生变化。
旨在进一步明确稳定人群中的PCC/PGLs特征。
一项回顾性单机构研究分析了2010年1月至2019年1月期间因PCC/PGLs接受肾上腺切除术的患者。记录了人口统计学资料、症状、血压、术前激素水平、影像学检查、组织学检查、住院时间、并发症以及三个亚组[基于诊断方式——偶发瘤组(IG)、遗传组(GG)和症状组(SG)]。
86例患者中,IG组51例(59.3%),GG组10例(11.62%),SG组25例(29.06%)。发病率为5.30例/100万人口。IG组中33.34%的患者诊断延迟,平均间隔时间为22.95个月(4 - 120个月)。女性更常出现阵发性症状(PS)(p = 0.011)。有PS和典型症状的患者更年轻(p = 0.0087,p = 0.0004),且有PS的患者术后需要更多的血管活性药物(p = 0.014)。SG组术前激素水平更高(p = 0.0048),肿瘤更大(p = 0.0169),且女性更常见。与IG组(p = 0.0001)或SG组(p = 0.178)相比,GG组患者更年轻。
大多数患者为偶发且诊断延迟。如果有症状,患者更可能是年轻女性,激素水平较高且肿瘤较大。